Delta Accumulation, LLC Eli Lilly & CO Call Options Transaction History

Delta Accumulation, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $525,190 - $619,130	-1,000 Reduced 6.33%	14,800 $8.63 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.87 Million - $9.47 Million	15,800 New	15,800 $8.49 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.04 Million - $2.54 Million	8,700 Added 161.11%	14,100 $4.04 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.21 Million - $1.51 Million	5,400 New	5,400 $1.49 Million

3,728

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.